Now showing items 1-2 of 2

  • Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance) 

    Hatch, Ace J.; Sibley, Alexander B.; Starr, Mark D.; Brady, J. Chris; Jiang, Chen; Jia, Jingquan; Bowers, Daniel L.; Pang, Herbert; Owzar, Kouros; Niedzwiecki, Donna; Innocenti, Federico; Venook, Alan P.; Hurwitz, Herbert I.; Nixon, Andrew B.; Alliance for Clinical Trials in Oncology (2016-09)
    Circulating protein markers were assessed in patients with colorectal cancer (CRC) treated with cetuximab in CALGB 80203 to identify prognostic and predictive biomarkers. Patients with locally advanced or metastatic CRC ...
  • CCL2-CCR2 axis promotes metastasis of nasopharyngeal carcinoma by activating ERK1/2-MMP2/9 pathway 

    Yang, Jing; Lv, Xing; Chen, Jinna; Xie, Changqing; Xia, Weixiong; Jiang, Chen; Zeng, Tingting; Ye, Yanfang; Ke, Liangru; Yu, Yahui; Liang, Hu; Guan, Xin-Yuan; Guo, Xiang; Xiang, Yanqun (2016-03-29)
    Distant metastasis remains the major failure of nasopharyngeal carcinoma (NPC). In this study, the roles of chemokine C-C motif ligand 2 (CCL2), and its receptor chemokine C-C motif receptor type 2 (CCR2) on NPC metastasis ...